CVRx announces Humana Medicare Advantage coverage policy for Barostim therapy
CVRx Inc CVRX
$6.11
▲ +0.66%
(+$0.04)
Open
$6.13
Prev Close
$6.07
Day Range
$6.09 – $6.43
52W Range
$4.37 – $11.30
Market Cap
$162.13M
Beta
0.80
EPS (TTM)
$-2.04
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-06-30 |
| Shares Out. | 26,540,000 |
| Website | cvrx.com/ ↗ |
| Phone | 17634162850 |
CVRx Inc is a publicly traded company under the ticker symbol CVRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-05-01)
📰 Latest News for CVRX
CVRx Announces Humana Medicare Advantage Coverage Policy For The Company's Barostim Therapy, Effective May 1
12 Health Care Stocks Moving In Tuesday's Intraday Session
CVRX Inc (NASDAQ:CVRX) Q1 2026 Earnings Meet Revenue Estimates, Loss Slightly Narrower Than Expected
CVRx, Inc. (CVRX) Q1 2026 Earnings Call Transcript
Transcript : CVRx, Inc., Q1 2026 Earnings Call, May 11, 2026
CVRx: Q1 Earnings Snapshot
CVRx Affirms FY2026 Sales Guidance of $63.000M-$67.000M vs $65.119M Est.